Victoza is a GLP-1 Receptor Agonist, right?

Poonamcmi04 Mar, 2022Health

The goal of the GLP-1 (glucagon-like peptide-1) Receptor Agonists Step Therapy programme (Byetta/exenatide and Victoza/liraglutide) is to ensure that patients are appropriately selected based on product labelling, clinical recommendations, and/or clinical research. Which GLP-1 Receptor Agonist is the most beneficial for cardiovascular health? GLP-1 Receptor Agonist, on the other hand, have been used in recent clinical trials targeted at examining cardiovascular events. Only liraglutide and semaglutide outperformed placebo in terms of cardiovascular benefit.